Multicenter Phase II Trial of Combination Therapy with Meloxicam, a COX-2 Inhibitor, and Natural Interferon-{alpha} for Metastatic Renal Cell Carcinoma

N Shinohara, A Kumagai, K Kanagawa, S Maruyama, T Abe, A Sazawa and K. Nonomura

Japanese Journal of Clinical Oncology 39 ( 11 ): 720 - 726 , 2009